420 related articles for article (PubMed ID: 20505896)
1. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
2. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for actinic keratoses.
McIntyre WJ; Downs MR; Bedwell SA
Am Fam Physician; 2007 Sep; 76(5):667-71. PubMed ID: 17894135
[TBL] [Abstract][Full Text] [Related]
4. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
6. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
7. New and emerging topical approaches for actinic keratoses.
Del Rosso JQ
Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
[TBL] [Abstract][Full Text] [Related]
8. Actinic keratoses: past, present and future.
Fenske NA; Spencer J; Adam F
J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
[TBL] [Abstract][Full Text] [Related]
9. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
10. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
[TBL] [Abstract][Full Text] [Related]
11. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
[TBL] [Abstract][Full Text] [Related]
12. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of actinic keratosis].
Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of new treatment modalities for actinic keratosis.
Berman B; Villa AM; Ramirez CC
J Drugs Dermatol; 2006 Feb; 5(2):167-73. PubMed ID: 16485885
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of field cancerization.
Ulrich C
Cancer Treat Res; 2009; 146():439-46. PubMed ID: 19415223
[No Abstract] [Full Text] [Related]
17. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review.
Aggarwal I; Puyana C; Chandan N; Jetter N; Tsoukas M
Am J Clin Dermatol; 2024 May; 25(3):391-405. PubMed ID: 38351246
[TBL] [Abstract][Full Text] [Related]
18. Topical therapy for actinic keratoses: current and evolving therapies.
Weinberg JM
Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780
[TBL] [Abstract][Full Text] [Related]
19. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
20. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
